CA2669616C — Devices, systems and methods for medicament delivery
Assigned to kaleo Inc · Expires 2016-06-21 · 10y expired
What this patent protects
Apparatuses and methods for automatic medicament injection are described herein. In one embodiment, an apparatus includes a housing, an injection member at least partially disposed in the housing, and an actuator configured to be disposed within the housing. The actuator is confi…
USPTO Abstract
Apparatuses and methods for automatic medicament injection are described herein. In one embodiment, an apparatus includes a housing, an injection member at least partially disposed in the housing, and an actuator configured to be disposed within the housing. The actuator is configured to move the injection member between a first position and a second position. The actuator includes an energy storage member having a first configuration and a second configuration. The energy storage member is configured to produce a force when moved from the first configuration to the second configuration to move the injection member between its first position and its second position.
Drugs covered by this patent
- naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.